Literature DB >> 2960974

Preparation and purification of microplasmin.

H L Wu1, G Y Shi, M L Bender.   

Abstract

A catalytically active, human microplasmin was produced by incubation of [Lys]plasmin in buffer at pH 11.0 for up to 12 hr. The microplasmin was purified by affinity chromatography that used lysine-Sepharose and soybean trypsin inhibitor-Sepharose columns. It is homogeneous and pure by electrophoretic analysis in NaDodSO4/polyacrylamide gels and by gel filtration on a Superose 12 column. The molecular weight of the microplasmin determined by NaDodSO4 gel electrophoresis is 29,000 and 26,500 under reducing condition, whereas the molecular weight of native plasmin is 76,500. Microplasmin consists mainly of the ligh (B) chain of native human plasmin and possesses one active site per protein molecule when titrated with p-nitrophenyl p'-guanidinobenzoate. Microplasmin hydrolyzes the peptide substrate NH2-D-Val-Leu-Lys-p-nitroanilide (S-2251) with a Km of 0.361 +/- 0.017 mM and a kcat of 40.3 +/- 3.3 s-1 at pH 7.4 and 37 degrees C, whereas native plasmin has a Km of 0.355 +/- 0.002 mM and a kcat of 27.9 +/- 0.3 s-1 under the same conditions.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2960974      PMCID: PMC299528          DOI: 10.1073/pnas.84.23.8292

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  23 in total

1.  Partial characterization of a low molecular weight fragment derived from human plasminogen.

Authors:  L D Yecies; A P Kaplan
Journal:  Thromb Res       Date:  1979       Impact factor: 3.944

2.  Recombinant human Lys-plasmin and the Lys-plasmin . streptokinase complex.

Authors:  L Summaria; I Boreisha; R C Wohl; K C Robbins
Journal:  J Biol Chem       Date:  1979-07-25       Impact factor: 5.157

3.  Ageing of alpha-chymotrypsin: Cannibalistic and hydroxide ion reactions.

Authors:  H L Wu; A Wastell; M L Bender
Journal:  Proc Natl Acad Sci U S A       Date:  1981-07       Impact factor: 11.205

4.  Multiple gene duplication in the evolution of plasminogen. Five regions of sequence homology with the two internally homologous structures in prothrombin.

Authors:  H Claeys; L Sottrup-Jensen; M Zajdel; T E Petersen; S Magnusson
Journal:  FEBS Lett       Date:  1976-01-01       Impact factor: 4.124

5.  The specific mechanism of activation of human plasminogen to plasmin.

Authors:  L Summaria; B Hsieh; K C Robbins
Journal:  J Biol Chem       Date:  1967-10-10       Impact factor: 5.157

6.  Studies on the active center of human plasmin. Partial amino acid sequence of a peptide containing the active center serine residue.

Authors:  W R Groskopf; L Summaria; K C Robbins
Journal:  J Biol Chem       Date:  1969-07-10       Impact factor: 5.157

7.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

8.  Activation of human neo-plasminogen-Val442 by urokinase and streptokinase and a kinetic characterization of neoplasmin-Val442.

Authors:  J R Powell; F J Castellino
Journal:  J Biol Chem       Date:  1980-06-10       Impact factor: 5.157

9.  Isolation and characterization of native and lower molecular weight forms of sheep plasminogen.

Authors:  N F Paoni; B N Violand; F J Castellino
Journal:  J Biol Chem       Date:  1977-11-10       Impact factor: 5.157

10.  Isolation of a human plasmin-derived, functionally active, light (B) chain capable of forming with streptokinase an equimolar light (B) chain-streptokinase complex with plasminogen activator activity.

Authors:  L Summaria; K C Robbins
Journal:  J Biol Chem       Date:  1976-09-25       Impact factor: 5.157

View more
  12 in total

1.  Amorphous protein aggregates stimulate plasminogen activation, leading to release of cytotoxic fragments that are clients for extracellular chaperones.

Authors:  Patrick Constantinescu; Rebecca A Brown; Amy R Wyatt; Marie Ranson; Mark R Wilson
Journal:  J Biol Chem       Date:  2017-07-14       Impact factor: 5.157

2.  Characterization of a reduced form of plasma plasminogen as the precursor for angiostatin formation.

Authors:  Diego Butera; Troels Wind; Angelina J Lay; Julia Beck; Francis J Castellino; Philip J Hogg
Journal:  J Biol Chem       Date:  2013-12-12       Impact factor: 5.157

3.  Structure and formation of microplasmin.

Authors:  H L Wu; G Y Shi; R C Wohl; M L Bender
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

4.  Proteolytic resistance conferred to fibrinogen by von Willebrand factor.

Authors:  A Tanka-Salamon; K Kolev; R Machovich; E Komorowicz
Journal:  Thromb Haemost       Date:  2009-12-18       Impact factor: 5.249

5.  Function of streptokinase fragments in plasminogen activation.

Authors:  G Y Shi; B I Chang; S M Chen; D H Wu; H L Wu
Journal:  Biochem J       Date:  1994-11-15       Impact factor: 3.857

6.  In vitro fibrinolysis and antithrombosis characterizations of novel recombinant microplasminogen with RGD and GPRP peptides.

Authors:  Wu Chen; Yi Li; Pin Chen; Maocai Wu; Lihua Wang; Hua Zhang; Laiyou Wang
Journal:  J Thromb Thrombolysis       Date:  2016-07       Impact factor: 2.300

7.  High-level expression, purification, and enzymatic characterization of truncated human plasminogen (Lys531-Asn791) in the methylotrophic yeast Pichia pastoris.

Authors:  Rongzeng Liu; Bing Zhao; Yanling Zhang; Junxiang Gu; Mingrong Yu; Houyan Song; Min Yu; Wei Mo
Journal:  BMC Biotechnol       Date:  2015-06-09       Impact factor: 2.563

Review 8.  Profile of ocriplasmin and its potential in the treatment of vitreomacular adhesion.

Authors:  Francisco R Stefanini; Maurício Maia; Paulo Falabella; Marcel Pfister; Moritz Niemeyer; Amir H Kashani; Mark S Humayun; Michael J Koss
Journal:  Clin Ophthalmol       Date:  2014-05-06

9.  Novel Thrombolytic Drug Based on Thrombin Cleavable Microplasminogen Coupled to a Single-Chain Antibody Specific for Activated GPIIb/IIIa.

Authors:  Thomas Bonnard; Zachary Tennant; Be'Eri Niego; Ruchi Kanojia; Karen Alt; Shweta Jagdale; Lok Soon Law; Sheena Rigby; Robert Lindsay Medcalf; Karlheinz Peter; Christoph Eugen Hagemeyer
Journal:  J Am Heart Assoc       Date:  2017-02-03       Impact factor: 5.501

Review 10.  Ocriplasmin for vitreoretinal diseases.

Authors:  Irena Tsui; Carolyn K Pan; Ehsan Rahimy; Steven D Schwartz
Journal:  J Biomed Biotechnol       Date:  2012-10-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.